Clinical Trials Browser

OTHER × Neoplasms, Unknown Primary × Erlotinib Hydrochloride × Clear all

NCT00360360 2013-12-04

Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site

Phase 2 Completed

60 enrolled 6 charts

Neoplasms, Unknown Primary

NCT00193622 2010-09-17

Bevacizumab and Erlotinib in the Treatment of Patients With Carcinoma of Unknown Primary Site

Phase 2 Completed

Neoplasms, Unknown Primary